| Financial Year |
March 31 2023 |
| Monetary Funds |
1,404,630,119.70 |
| Held-for-trading Financial Assets |
130,164,712.33 |
| Notes Receivable |
103,880,179.24 |
| Accounts Receivable |
743,322,909.29 |
| Advances to Suppliers |
272,995,599.18 |
| Other Receivables |
44,720,235.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,061,517,554.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,804,165.30 |
| Total Current Assets |
4,839,665,243.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
142,792,812.68 |
| Investment Properties |
-- |
| Fixed Assetes |
396,517,097.14 |
| Under-construction Projects |
27,765,190.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,839,149.30 |
| R&D expenses |
-- |
| Goodwill |
1,097,041,685.85 |
| Long-Term Deferred and Prepaid Expenses |
100,113,693.75 |
| Deferred Income Tax Assets |
236,789,263.74 |
| Other Non-Current Assets |
127,330,046.21 |
| Sub-Total of Non-Current Assets |
3,219,716,002.82 |
| Total Assets |
8,059,381,246.23 |
| Short-Term Loans |
989,677,435.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
483,934,216.24 |
| Accounts Payable |
1,463,489,926.89 |
| Accounts Received In Advance |
5,136,124.49 |
| Employee Compensation Payable |
81,656,865.58 |
| Taxes Payable |
69,530,999.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
92,513,587.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
450,746,496.50 |
| Other Current Liabilities |
432,151,934.60 |
| Sub-Total of Current Liabilities |
4,139,981,528.20 |
| Long-term Loans |
372,660,000.00 |
| Bonds Payable |
657,108,586.99 |
| Long-Term Accounts Payable |
1,151,896.24 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
192,048,526.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,585,157,465.64 |
| Total Liabilities |
5,725,138,993.84 |
| Paid-In Capital(Or Share Stock) |
405,340,000.00 |
| Capital Surplus |
857,572,222.26 |
| Surplus Reserve |
55,934,775.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
835,521,762.39 |
| Minority Stockholder's Interest |
37,827,250.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,296,415,001.54 |
| Owner's Equity（Stockholder's Equity） |
2,334,242,252.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,059,381,246.23 |
